Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study

Kazutaka Kikuta, Turrent Robert Nakayama, Sayaka Yamaguchi, Yuuji Nishiwaki, Michiro Susa, Kazumasa Nishimoto, Keisuke Horiuchi, Masaya Nakamura, Morio Matsumoto, Hideo Morioka

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Subcutaneous malignant tumors are often treated by non-specialized clinicians in musculoskeletal oncology. While the resection of subcutaneous tumors appears technically feasible, unplanned resection of malignant tumors can result in a devastating clinical outcome. The aim of this study was to evaluate the potential estrangement in the awareness of and the treatment strategy for the patients with subcutaneous soft tissue tumors between musculoskeletal oncologists and non-specialized clinicians. Methods: A questionnaire probing the clinical assessment of subcutaneous tumors was sent to orthopedic surgeons, dermatologists, plastic surgeons, and general surgeons. Results of the questionnaire were statistically analyzed. Results: One hundred sixteen clinicians out of 150 responded to the questionnaire; the response rate was 77.3%. Among those, 46 clinicians had treated subcutaneous tumors. Thirty-nine of these 46 clinicians (27 musculoskeletal oncologists and 12 non-specialized clinicians) preoperatively performed enhanced MRI for diagnostic evaluation. Preoperative incisional biopsy to confirm the pathological diagnosis was performed by 36 of the 46 clinicians (29 musculoskeletal oncologists and seven non-specialized clinicians). These results indicate that musculoskeletal oncologists perform preoperative enhanced MRI (P = 0.08) and biopsy (P < 0.01) more frequently than nonspecialized clinicians. The recognition rate of 'myxofibrosarcoma' was 60.8% among clinicians with an experience with sarcoma treatment (25 musculoskeletal oncologists and three nonspecialized clinicians). The recognition rate of 'myxofibrosarcoma' between musculoskeletal oncologists and non-specialized clinicians was statistically significant (P < 0.01). Conclusions: Preoperative evaluations for subcutaneous tumors are more often inappropriate in non-specialized clinicians than those who are. Therefore, it will be mandatory to raise the awareness of this condition to improve the clinical outcome of patients with subcutaneous tumors.

Original languageEnglish
Pages (from-to)130-134
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume48
Issue number2
DOIs
Publication statusPublished - 2018 Feb 1

Fingerprint

Neoplasms
Therapeutics
Biopsy
Surveys and Questionnaires
Subcutaneous Tissue
Sarcoma
Oncologists
Surgeons

Keywords

  • Myxofibrosarcoma
  • Questionnaire study
  • Subcutaneous soft tissue tumors

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study. / Kikuta, Kazutaka; Nakayama, Turrent Robert; Yamaguchi, Sayaka; Nishiwaki, Yuuji; Susa, Michiro; Nishimoto, Kazumasa; Horiuchi, Keisuke; Nakamura, Masaya; Matsumoto, Morio; Morioka, Hideo.

In: Japanese Journal of Clinical Oncology, Vol. 48, No. 2, 01.02.2018, p. 130-134.

Research output: Contribution to journalArticle

Kikuta, Kazutaka ; Nakayama, Turrent Robert ; Yamaguchi, Sayaka ; Nishiwaki, Yuuji ; Susa, Michiro ; Nishimoto, Kazumasa ; Horiuchi, Keisuke ; Nakamura, Masaya ; Matsumoto, Morio ; Morioka, Hideo. / Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study. In: Japanese Journal of Clinical Oncology. 2018 ; Vol. 48, No. 2. pp. 130-134.
@article{0958e408993c4beda8a7ee31eada2022,
title = "Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study",
abstract = "Background: Subcutaneous malignant tumors are often treated by non-specialized clinicians in musculoskeletal oncology. While the resection of subcutaneous tumors appears technically feasible, unplanned resection of malignant tumors can result in a devastating clinical outcome. The aim of this study was to evaluate the potential estrangement in the awareness of and the treatment strategy for the patients with subcutaneous soft tissue tumors between musculoskeletal oncologists and non-specialized clinicians. Methods: A questionnaire probing the clinical assessment of subcutaneous tumors was sent to orthopedic surgeons, dermatologists, plastic surgeons, and general surgeons. Results of the questionnaire were statistically analyzed. Results: One hundred sixteen clinicians out of 150 responded to the questionnaire; the response rate was 77.3{\%}. Among those, 46 clinicians had treated subcutaneous tumors. Thirty-nine of these 46 clinicians (27 musculoskeletal oncologists and 12 non-specialized clinicians) preoperatively performed enhanced MRI for diagnostic evaluation. Preoperative incisional biopsy to confirm the pathological diagnosis was performed by 36 of the 46 clinicians (29 musculoskeletal oncologists and seven non-specialized clinicians). These results indicate that musculoskeletal oncologists perform preoperative enhanced MRI (P = 0.08) and biopsy (P < 0.01) more frequently than nonspecialized clinicians. The recognition rate of 'myxofibrosarcoma' was 60.8{\%} among clinicians with an experience with sarcoma treatment (25 musculoskeletal oncologists and three nonspecialized clinicians). The recognition rate of 'myxofibrosarcoma' between musculoskeletal oncologists and non-specialized clinicians was statistically significant (P < 0.01). Conclusions: Preoperative evaluations for subcutaneous tumors are more often inappropriate in non-specialized clinicians than those who are. Therefore, it will be mandatory to raise the awareness of this condition to improve the clinical outcome of patients with subcutaneous tumors.",
keywords = "Myxofibrosarcoma, Questionnaire study, Subcutaneous soft tissue tumors",
author = "Kazutaka Kikuta and Nakayama, {Turrent Robert} and Sayaka Yamaguchi and Yuuji Nishiwaki and Michiro Susa and Kazumasa Nishimoto and Keisuke Horiuchi and Masaya Nakamura and Morio Matsumoto and Hideo Morioka",
year = "2018",
month = "2",
day = "1",
doi = "10.1093/jjco/hyx184",
language = "English",
volume = "48",
pages = "130--134",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study

AU - Kikuta, Kazutaka

AU - Nakayama, Turrent Robert

AU - Yamaguchi, Sayaka

AU - Nishiwaki, Yuuji

AU - Susa, Michiro

AU - Nishimoto, Kazumasa

AU - Horiuchi, Keisuke

AU - Nakamura, Masaya

AU - Matsumoto, Morio

AU - Morioka, Hideo

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Background: Subcutaneous malignant tumors are often treated by non-specialized clinicians in musculoskeletal oncology. While the resection of subcutaneous tumors appears technically feasible, unplanned resection of malignant tumors can result in a devastating clinical outcome. The aim of this study was to evaluate the potential estrangement in the awareness of and the treatment strategy for the patients with subcutaneous soft tissue tumors between musculoskeletal oncologists and non-specialized clinicians. Methods: A questionnaire probing the clinical assessment of subcutaneous tumors was sent to orthopedic surgeons, dermatologists, plastic surgeons, and general surgeons. Results of the questionnaire were statistically analyzed. Results: One hundred sixteen clinicians out of 150 responded to the questionnaire; the response rate was 77.3%. Among those, 46 clinicians had treated subcutaneous tumors. Thirty-nine of these 46 clinicians (27 musculoskeletal oncologists and 12 non-specialized clinicians) preoperatively performed enhanced MRI for diagnostic evaluation. Preoperative incisional biopsy to confirm the pathological diagnosis was performed by 36 of the 46 clinicians (29 musculoskeletal oncologists and seven non-specialized clinicians). These results indicate that musculoskeletal oncologists perform preoperative enhanced MRI (P = 0.08) and biopsy (P < 0.01) more frequently than nonspecialized clinicians. The recognition rate of 'myxofibrosarcoma' was 60.8% among clinicians with an experience with sarcoma treatment (25 musculoskeletal oncologists and three nonspecialized clinicians). The recognition rate of 'myxofibrosarcoma' between musculoskeletal oncologists and non-specialized clinicians was statistically significant (P < 0.01). Conclusions: Preoperative evaluations for subcutaneous tumors are more often inappropriate in non-specialized clinicians than those who are. Therefore, it will be mandatory to raise the awareness of this condition to improve the clinical outcome of patients with subcutaneous tumors.

AB - Background: Subcutaneous malignant tumors are often treated by non-specialized clinicians in musculoskeletal oncology. While the resection of subcutaneous tumors appears technically feasible, unplanned resection of malignant tumors can result in a devastating clinical outcome. The aim of this study was to evaluate the potential estrangement in the awareness of and the treatment strategy for the patients with subcutaneous soft tissue tumors between musculoskeletal oncologists and non-specialized clinicians. Methods: A questionnaire probing the clinical assessment of subcutaneous tumors was sent to orthopedic surgeons, dermatologists, plastic surgeons, and general surgeons. Results of the questionnaire were statistically analyzed. Results: One hundred sixteen clinicians out of 150 responded to the questionnaire; the response rate was 77.3%. Among those, 46 clinicians had treated subcutaneous tumors. Thirty-nine of these 46 clinicians (27 musculoskeletal oncologists and 12 non-specialized clinicians) preoperatively performed enhanced MRI for diagnostic evaluation. Preoperative incisional biopsy to confirm the pathological diagnosis was performed by 36 of the 46 clinicians (29 musculoskeletal oncologists and seven non-specialized clinicians). These results indicate that musculoskeletal oncologists perform preoperative enhanced MRI (P = 0.08) and biopsy (P < 0.01) more frequently than nonspecialized clinicians. The recognition rate of 'myxofibrosarcoma' was 60.8% among clinicians with an experience with sarcoma treatment (25 musculoskeletal oncologists and three nonspecialized clinicians). The recognition rate of 'myxofibrosarcoma' between musculoskeletal oncologists and non-specialized clinicians was statistically significant (P < 0.01). Conclusions: Preoperative evaluations for subcutaneous tumors are more often inappropriate in non-specialized clinicians than those who are. Therefore, it will be mandatory to raise the awareness of this condition to improve the clinical outcome of patients with subcutaneous tumors.

KW - Myxofibrosarcoma

KW - Questionnaire study

KW - Subcutaneous soft tissue tumors

UR - http://www.scopus.com/inward/record.url?scp=85042906950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042906950&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyx184

DO - 10.1093/jjco/hyx184

M3 - Article

C2 - 29294111

AN - SCOPUS:85042906950

VL - 48

SP - 130

EP - 134

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 2

ER -